Implementation of ERAS in pancreaticoduodenectomy in an Australian tertiary centre
Pancreatology · 2023
DOI: 10.1016/j.pan.2023.06.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2023. Verfasst von Sharnice A Koek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Fiona Stanley Hospital, Murdoch, WA, Australia; Medical School, The University of Western Australia, Perth, WA, Austra…. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Enhanced Recovery After Surgery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Spinnaker Health Research Foundation.
Abstract (Originalsprache)
BACKGROUND/OBJECTIVES: Recent studies have demonstrated that enhanced recovery after surgery (ERAS) protocols in pancreaticoduodenectomy (PD) may decrease morbidity and length of stay. This study aimed to critically assess the implementation of ERAS in patients who have undergone a PD in a tertiary centre. METHODS: A retrospective cohort study of all patients who underwent a PD prior to ERAS, compared to following implementation were assessed. Outcome measures of length of stay, morbidity, mortality and readmission rates between the two groups were evaluated. RESULTS: 169 patients were included in the study (pre-ERAS, n = 29; stage 1, n = 14; stage 2, n = 53, stage 3, n = 73) with mean age of 64 ± 11.3 years. ERAS significantly increased the proportion of patients reaching the target length of stay of nine days (P = 0.017). It did not significantly impact overall mortality, morbidity, radiological intervention, reoperation or readmission (P > 0.05). ERAS did not have a significant impact on development of pancreatic fistula, ileus, infection or haemorrhage (P > 0.05). ERAS did significantly reduce rates of delayed gastric emptying (DGE) from 82.8% pre-ERAS to 49.0% in the stage 2 of implementation phase (P < 0.001). CONCLUSIONS: The early implementation of the ERAS programme was safe although some obstacles were encountered. ERAS was beneficial in increasing the proportion of patients reaching the target length of stay without increasing readmission, reoperation, or morbidity. Our findings support the continued development of ERAS in PD in order to standardise care and improve patient recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Fiona Stanley Hospital, Murdoch, WA, Australia; Medical School, The University of Western Australia, Perth, WA, Australia. Electronic address: Sharnice.Koek@health.wa.gov.au.
- Department of General Surgery, Fiona Stanley Hospital, Murdoch, WA, Australia; Medical School, The University of Western Australia, Perth, WA, Australia.
Förderung
- Spinnaker Health Research Foundation
Zitieren
APA
Koek, S. A., & Ballal, M. S. (2023). Implementation of ERAS in pancreaticoduodenectomy in an Australian tertiary centre. Pancreatology. https://doi.org/10.1016/j.pan.2023.06.004
Vancouver
Koek SA, Ballal MS. Implementation of ERAS in pancreaticoduodenectomy in an Australian tertiary centre. Pancreatology. 2023. doi:10.1016/j.pan.2023.06.004
BibTeX
@article{Koek2023,
author = {Koek, Sharnice A and Ballal, Mohammed S},
title = {Implementation of ERAS in pancreaticoduodenectomy in an Australian tertiary centre},
journal = {Pancreatology},
year = {2023},
doi = {10.1016/j.pan.2023.06.004}
}
EUVIMED